In contrast to the variegated, HDAC-mediated silencing of newly retrotransposed L1 integrants in cultured cancer cells, new L1 insertions in mouse ES cells were silenced by dense de novo CpG methylation (Figs. 5 and 8). The gene discussed is HDAC9; the disease is cancer.